222 related articles for article (PubMed ID: 35962406)
41. Better Failure-Free Survival and Graft-versus-Host Disease-Free/Failure Free Survival with Fludarabine-Based Conditioning in Stem Cell Transplantation for Aplastic Anemia in Children.
Im SH; Kim BR; Park SM; Yoon BA; Hwang TJ; Baek HJ; Kook H
J Korean Med Sci; 2020 Feb; 35(7):e46. PubMed ID: 32080987
[TBL] [Abstract][Full Text] [Related]
42. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
[TBL] [Abstract][Full Text] [Related]
43. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
Gao Q; Zhang L; Zhao X; Zhu Y; Peng G; Li Y; Li Y; Li J; Song L; Ye L; Fan H; Zhou K; Yang W; Yang Y; Jing L; Zhang F
Hematology; 2020 Dec; 25(1):341-347. PubMed ID: 32915111
[No Abstract] [Full Text] [Related]
44. Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study.
Giammarco S; Sica S; Chiusolo P; Laurenti L; Sorá F; Martino M; Metafuni E; Busca A; Risitano A; Vallejo C; Bacigalupo A
Int J Hematol; 2021 Aug; 114(2):228-234. PubMed ID: 33886103
[TBL] [Abstract][Full Text] [Related]
45. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study.
Li Y; Duan F; Xiao H; Wu X; Wang S; Xu D; Liu Q; Fan Z; Nie D; Lai Y; Wu B; Lin D; Du X; Weng J; Jiang Z; Pang Y; Ouyang L; Liu Z; Zhang L; Han N; Chen L; Xiao Y
Transplantation; 2018 Oct; 102(10):1724-1731. PubMed ID: 29677078
[TBL] [Abstract][Full Text] [Related]
47. Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.
Samarasinghe S; Steward C; Hiwarkar P; Saif MA; Hough R; Webb D; Norton A; Lawson S; Qureshi A; Connor P; Carey P; Skinner R; Vora A; Pelidis M; Gibson B; Stewart G; Keogh S; Goulden N; Bonney D; Stubbs M; Amrolia P; Rao K; Meyer S; Wynn R; Veys P
Br J Haematol; 2012 May; 157(3):339-46. PubMed ID: 22372373
[TBL] [Abstract][Full Text] [Related]
48. Hematopoietic stem cell transplantation without in vivo T-cell depletion for pediatric aplastic anemia: A single-center experience.
Li S; Wang B; Fu L; Pang Y; Zhu G; Zhou X; Ma J; Su Y; Qin M; Wu R
Pediatr Transplant; 2018 Aug; 22(5):e13204. PubMed ID: 29744996
[TBL] [Abstract][Full Text] [Related]
49. Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan.
Foucar CE; Foley DH; Aldous J; Burke PW; Pettit KR; Benitez LL; Perissinotti AJ; Marini BL; Boonstra P; Bixby DL
Eur J Haematol; 2024 Mar; 112(3):424-432. PubMed ID: 37929654
[TBL] [Abstract][Full Text] [Related]
50. Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
Qin X; Zhu YP; Luo CJ; Zhou M; Huang K; Chen C; Zhang WP; Sun Y; Luo RM; Tang XF; Yang T; Song XM; Hu SY; Sun ZM; Hu J; Wang SQ; Chen J
Ann Hematol; 2021 Sep; 100(9):2363-2373. PubMed ID: 33988738
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
[TBL] [Abstract][Full Text] [Related]
52. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
53. Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag.
Li R; Zhou J; Liu Z; Chen X; Long Q; Yang Y; Lin S; Jia J; He G; Li J
Front Immunol; 2022; 13():884312. PubMed ID: 35720405
[TBL] [Abstract][Full Text] [Related]
54. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
[TBL] [Abstract][Full Text] [Related]
55. Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.
Liu L; Miao M; He H; Wang S; Zhang Y; Guo A; Jiao W; Lei M; Cai Y; Shangguan X; Liu Z; Xu J; Li X; Zhang L; Wu D
Front Immunol; 2022; 13():955095. PubMed ID: 36131940
[TBL] [Abstract][Full Text] [Related]
56. The prognostic impact of previously infectious complications on allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia: A single-center, retrospective study.
Zhang Y; Chen X; Yang D; Pang A; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Feng S
Front Immunol; 2022; 13():1004787. PubMed ID: 36172387
[TBL] [Abstract][Full Text] [Related]
57. [Acquired aplastic anemia: recent advances in pathophysiology and treatment].
Yamazaki H
Rinsho Ketsueki; 2018; 59(6):711-715. PubMed ID: 29973449
[TBL] [Abstract][Full Text] [Related]
58. Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag.
Zaimoku Y; Patel BA; Shalhoub R; Groarke EM; Feng X; Wu CO; Young NS
Haematologica; 2022 Jan; 107(1):126-133. PubMed ID: 33910334
[TBL] [Abstract][Full Text] [Related]
59. Immunosuppressive therapy in severe aplastic anemia.
Patel BA; Townsley DM; Scheinberg P
Semin Hematol; 2022 Jan; 59(1):21-29. PubMed ID: 35491055
[TBL] [Abstract][Full Text] [Related]
60. [A retrospective comparative study of haplotype hematopoietic stem cell transplantation and human leukocyte antigen-matched sibling donor hematopoietic stem cell transplantation in the treatment of acute B-lymphocyte leukemia].
Wang ZD; Sun YQ; Yan CH; Wang FR; Mo XD; Lyu M; Zhao XS; Han W; Chen H; Chen YY; Wang Y; Xu LP; Wang YZ; Liu YR; Cheng YF; Zhang XH; Liu KY; Huang XJ; Chang YJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):221-228. PubMed ID: 35405780
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
